Medication info
DMtatin Tablets (Pitavastatin Calcium Hydrate)

DMtatin Tablets (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›2mg / 1 tablet
Manufacturer / importer
Unimed Pharmaceuticals Co., Ltd.
Appearance
Very pale yellowish-red round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201901754 · Approved 2019.03.25 · Insurance code 649508380

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is pitavastatin calcium 1~2 milligrams once daily after the evening meal. If the LDL-cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Depending on LDL-cholesterol levels, treatment goals, and patient response, adjust the dose as appropriate at intervals of 4 weeks or longer. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
Unimed Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • dyslipidemia
  • elevated total cholesterol
  • LDL cholesterol
  • apo-B protein
  • triglyceride levels
View approved original text

This medication helps improve cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It specifically lowers total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels, while increasing HDL cholesterol to improve the balance of lipids in the blood. This medication is effective in managing dyslipidemia in conjunction with dietary therapy. It contributes to reducing the risk of cardiovascular diseases due to cholesterol. Therefore, this medication is used for the treatment of hypercholesterolemia and dyslipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is pitavastatin calcium 1~2 milligrams once daily after the evening meal. If the LDL-cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Depending on LDL-cholesterol levels, treatment goals, and patient response, adjust the dose as appropriate at intervals of 4 weeks or longer. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication should not be used in certain patients. For example, patients who have had allergic reactions to this medication, patients with liver problems or consistently elevated liver function test results, patients with severe liver impairment or bile duct obstruction, patients taking cyclosporine, patients with myopathy, pregnant or potentially pregnant women and nursing mothers, and children should not receive this medication. In addition, it should be used with caution in patients with impaired kidney function or a history of liver disease, those who consume alcohol excessively, patients with hypothyroidism or a history of muscle-related diseases, and the elderly, as the risk of side effects may increase when used with specific medications, resulting in muscle damage or worsening kidney function. While taking this medication, symptoms such as muscle pain, fatigue, abdominal pain, rash, and itching may occur, and serious side effects such as liver dysfunction, blood abnormalities, and kidney dysfunction may also arise, necessitating regular tests. If severe muscle pain or weakness occurs, use should be discontinued immediately and medical consultation sought. Additionally, regular liver function tests should be conducted before and during treatment to detect any abnormal signs early. This medication is used to treat hyperlipidemia, so before use, it is recommended to confirm hypercholesterolemia and to incorporate dietary and exercise therapies. If there is no therapeutic effect, use should be stopped. This medication should not be administered to patients with certain genetic disorders, and since it can interact with other drugs, any medications currently being taken must be disclosed to healthcare providers. In elderly patients, the risk of side effects may be increased due to reduced bodily functions, so dosage adjustments and careful monitoring are required. Pregnant or nursing patients should refrain from taking this medication due to potential effects on the fetus and newborn, and use should be discontinued immediately if pregnancy is confirmed. Finally, this medication should not be used in children as its safety and efficacy have not been established.

Side effects

  • Abdominal pain
  • rash
  • fatigue
  • paralysis
  • itching
  • muscle pain
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 79 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • dry mouth
  • indigestion
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • agranulocytosis
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • polyuria
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • increased adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • fatigue
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • joint pain
  • swelling
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • taste abnormalities
  • positive antinuclear antibody
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • facial swelling
  • arm swelling
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light; therefore, it should be stored in a container that does not permit light exposure. Additionally, it is important to keep the medication at room temperature, between 1 degree and 30 degrees Celsius. This will help maintain the effectiveness of the medication for an extended period.

Appearance and packaging

Appearance

Very pale yellowish-red round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.